Mirum Pharmaceuticals (MIRM) 8-K Summary

Mirum Pharmaceuticals filed this Form 8-K on November 4, 2025, to report on financial results.

Key Event

• The company issued a press release announcing financial results for the quarter ended September 30, 2025.

Investor Action

• Full details, including specific financial metrics and any corporate updates, are contained in Exhibit 99.1 (the furnished press release).
• Note: This 8-K itself does not list the financial figures; investors must review Exhibit 99.1 for performance data.

Status

• Filed under Item 2.02.